Deltex Medical, the makers of a device which monitors blood flow during and after operations, says it is beginning to benefit from an official recommendation by the National Institute for Health and Clinical Excellence (NICE).
In March last year NICE recommended that the CardioQ-ODM system be considered for use in all patients undergoing major and high risk surgery in the NHS. Since December Deltex has seen a 40% increase in sales of its surgical probes compared to the prior year.
The firm still awaits the adoption of ODM as one of six "high impact" technologies to be implemented in the NHS but is pinning its hopes on a report to be published this Summer which may give the official stamp of approval.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
By 11:30 the stock had risen 2.7%.
BS
-
Scammers steal over £600 million from Brits - how to protect yourselfFraud cases in the first half of the year surged by 17% compared to the same period in 2024. Is your money at risk?
-
Financial support for carers: what can you get?Unpaid carers miss out on an average £6,400 a year in annual salary by cutting work to support loved ones. We explore benefits that can plug the financial gap.
